Article: Heart rhythm drugs worse than no treatment. (quinidine)

People treated with quinidine for abnormal heart rhythms (arrhythmias) are more likely to die of an adverse reaction to the drug than of the condition itself, according to a new meta-analysis* (Circulation, November 1991). It also discovered that quinidine, although widely used for over half a century, may have an even greater risk of causing fatal adverse reactions than two newer, highly toxic antiarrhythmia drugs, encainide and flecainide.

In 1989, a National Institutes of Health (NIH) study found that people given either encainide (brand name: Enkaid) or flecainide (brand name: Tambocor) were twice as likely to die as those given a placebo. Although the two ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!